Newsfeeds Archive - Spark Newswire

1 minute read

AIM ImmunoTech Completes cGMP Manufacturing Of Clinical Vials Of Ampligen

May 6, 8:38 AM

AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced the successfully completion of cGMP manufacturing of 9,042 clinical vials of Ampligen® (rintatolimod), AIM's dsRNA product candidate being

AIM

1 minute read

Earnings

Earnings Scheduled For April 2, 2024

By Benzinga Insights

April 2, 6:25 AM

Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter.

ABVX

1 minute read

Earnings

Preview: AIM ImmunoTech’s Earnings

By Benzinga Insights

April 1, 2:05 PM

AIM ImmunoTech (AMEX:AIM) will release its quarterly earnings report on Tuesday, 2024-04-02. Here’s a brief overview for investors…

AIM

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

February 12, 5:30 PM

Gainers BioSig Technologies (NASDAQ:BSGM) stock increased by 7.7% to $0.96 during Monday’s after-market session. The company’s market cap…

AIM

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

January 23, 5:31 PM

Gainers Redhill Biopharma (NASDAQ:RDHL) shares rose 11.1% to $0.99 during Tuesday’s after-market session. The market value of their…

AIM

3 minute read

AIM ImmunoTech Announces That The First Subject Is Enrolled In The Phase 1b/2 Study Evaluating Ampligen In Combination With AstraZeneca’s Imfinzi For The Treatment Of Late-Stage Pancreatic Cancer

By Benzinga Newsdesk

January 22, 9:55 AM

AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that the first subject has been enrolled at Erasmus Medical Center ("Erasmus MC") in a Phase 1b/2 clinical trial combining AIM's Ampligen®

AIM

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

January 11, 9:05 AM

Gainers Atreca (NASDAQ:BCEL) stock moved upwards by 63.4% to $0.17 during Thursday’s pre-market session. The market value of…

AIM

2 minute read

AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying

By Lisa Levin

November 28, 7:39 AM

The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AIM

2 minute read

AIM ImmunoTech Completes Treatment Of Last Subject In Phase 2 Study Evaluating Ampligen For The Treatment Of Post-COVID Conditions

By Benzinga Newsdesk

November 21, 1:01 PM

No severe adverse events reported to dateTopline data expected as early as Q1 2024OCALA, Fla., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced the last

AIM

4 minute read

Earnings

Earnings Scheduled For November 15, 2023

By Benzinga Insights

November 15, 8:30 AM

Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is likely to report earnings for its third quarter. • Movano (NASDAQ:MOVE) is projected to report earnings for its third quarter.

AAP